David is a 50-year-old teacher and former athlete who had been living with genetically confirmed facioscapulohumeral muscular dystrophy (FSHD) for years. His father and both brothers carry the same genetic diagnosis, though the severity varies among family members.

Seven years before coming to Dr. Lamb’s clinic, David suffered a traumatic fall while coaching hockey. The fall triggered post-concussion syndrome that persisted and worsened over time. Sometime after this injury, he began experiencing progressive upper and lower limb weakness. What started as isolated symptoms evolved into a complex clinical picture: constant bilateral tinnitus, severe light sensitivity, chronic migraines, cognitive fog, and profound muscle weakness that limited nearly every aspect of his life.

FSHD is a progressive genetic disorder affecting approximately 12 in every 100,000 people. It causes weakness in the facial muscles, shoulder muscles, and the muscles that control ankle movement. FSHD has no approved disease-modifying therapy. As of 2025, there is no cure. Standard care is supportive only. Patients are expected to experience progressive decline.

His outlook under standard care was continued progression, as no approved medical interventions exist that stop or reverse FSHD weakness.

The Initial Assessment

When David came to Dr. Lamb in July 2022, his functional limitations were severe. His shoulders were so weak he could only lift his arms sideways to about 50 to 80 degrees. He could not raise them overhead. He had bilateral foot drop affecting his walking. His legs felt heavy. He could not climb stairs easily or walk long distances. He could not play golf, something he had once enjoyed. He experienced constant migraines, light sensitivity, tinnitus in both ears, and cognitive difficulties.

From a standard neurological perspective, this was simply FSHD progressing as expected.

Dr. Lamb also conducted a structured Neuromyofascial Audit, a systematic palpation-based assessment designed to identify injury patterns that may not appear on conventional imaging. The audit involves detailed examination of the spine, muscles, fascia, and neurological structures to map where mechanical restriction and scarring might be contributing to symptoms.

The audit identified findings consistent with dense post-traumatic scarring in David’s cervical and thoracic spine, in the region of his hockey injury seven years earlier. The clinical impression was that this scarring had contributed to functional spinal stenosis (narrowing related to muscular and fascial restriction rather than bone overgrowth) and central spinal tethering. These are palpation-based clinical impressions; conventional MRI and CT imaging had not identified corresponding abnormalities.

Dr. Lamb’s hypothesis was straightforward: while FSHD is a genetic condition that cannot be cured, David’s functional decline might be amplified by treatable mechanical pathology from his previous injury. If that mechanical component could be released, some function might return.

The Treatment and Immediate Response

In July 2022, David received targeted Transcutaneous Neuromyofascial Precision Care (TNPC) focused on releasing the identified areas of fibrosis, decompressing tethered nerve structures, and improving segmental spinal mobility. The session lasted approximately 30 minutes.

Within 30 minutes of the session, examination documented immediate functional changes.

On examination immediately after treatment, David’s right shoulder abduction, measured at 50 to 80 degrees before the session, reached full overhead elevation. The left arm showed the same result: full range of motion with control.

The improvements did not stop there. Over the following 40 minutes, continued observation documented further improvement.

David reported that not only had his shoulder strength returned, but his vision felt clearer. His constant headaches had significantly reduced. The tinnitus that had been constant for years was markedly improved.

The Sustained Recovery

Three years later, through 2025, David’s functional improvements have persisted and continued to consolidate.

He can now play golf approximately once per week, something he had been unable to do before treatment. He walks significantly longer distances without fatigue.

He reports improvements across daily activities: sleeping better, clearer cognition, and headaches and tinnitus that are greatly reduced rather than constant.

On examination, his strength and shoulder range of motion remain full, and the foot drop has not returned.

He has received periodic maintenance treatment approximately every six months to sustain these gains, particularly as he has returned to more active pursuits including sports.

What This Means

FSHD is a genetic condition. Treatment with TNPC does not cure FSHD or reverse the underlying genetic mutation. David’s genetic diagnosis has not changed.

What has changed is that a suspected mechanical contributor to his disability was identified and addressed.

Dr. Lamb’s clinical interpretation is that FSHD may create vulnerability to certain types of spinal restriction and tethering, particularly when superimposed with prior injury. While the genetic myopathy itself cannot be modified, the mechanical spinal pathology that compounds the disability may be.

This case suggests something important: in patients with neuromuscular genetic diseases like FSHD, there may be a layer of mechanical pathology that is modifiable. Identifying and treating that mechanical component may allow recovery of function that had appeared permanently lost.

Where Things Stand

David had accepted that his FSHD would progressively worsen, that his disability would increase, and that functional recovery was not possible. The standard medical understanding of FSHD supported this expectation.

The neuromyofascial assessment and treatment changed that trajectory in his case. Three years post-procedure, David reports his quality of life is substantially improved. He plays golf. He walks. He sleeps better. He describes clearer cognition, and headaches and tinnitus that are manageable rather than dominating.